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ABSTRACT
Chromatin-remodeling complexes regulate the ex-
pression of genes in all eukaryotic genomes. The
SWI/SNF complex of Saccharomyces cerevisiae is
recruited to its target promoters via interactions
with selected transcription factors. Here, we show
that the N-terminus of Snf2p, the chromatin re-
modeling core unit of the SWI/SNF complex, is es-
sential for the expression of VHT1, the gene of the
plasma membrane H
+/biotin symporter, and of
BIO5, the gene of a 7-keto-8-aminopelargonic acid
transporter, biotin biosynthetic precursor. chroma-
tin immunoprecipitation (ChIP) analyses demon-
strate that Vhr1p, the transcriptional regulator of
VHT1 and BIO5 expression, is responsible for the
targeting of Snf2p to the VHT1 promoter at low
biotin. We identified an Snf2p mutant, Snf2p-R15C,
that specifically abolishes the induction of VHT1 and
BIO5 but not of other Snf2p-regulated genes, such
as GAL1, SUC2 or INO1. We present a novel mech-
anism of target gene-specific SWI/SNF recruitment
via Vhr1p and a conserved N-terminal Snf2p domain.
INTRODUCTION
The Snf2p protein (synonym Swi2p) from baker’s yeast
(Saccharomyces cerevisiae) is the founding member of a
huge family of nuclear regulators that are ubiquitous in
eukaryotes, but found also in bacteria and archaea (1).
The SNF2 gene was originally identiﬁed in screens for
S. cerevisiae mutants defective in the expression of the
HO gene involved in mating type switching [SWI=
switching defective (2)] or for mutants affected in the
expression of the SUC2 gene encoding the yeast invertase
[SNF=sucrose non-fermenting (3)]. Snf2p family
proteins are DNA-dependent ATPases that share a
conserved region of helicase-related motifs (4). Most of
these proteins act as ATP-dependent DNA translocases
that can distort DNA and disrupt or remodel the structure
of chromatin (RSC) that otherwise blocks the access
of transcriptional activators or the basal transcrip-
tional machinery to recognition sequences within target
promoters (1).
In the cell, chromatin remodeling factors like Snf2p
work in conjunction with other proteins, and the resulting
complexes perform critical functions in the maintenance
and expression of the genome (5–7). Baker’s yeast has two
SWI/SNF-type remodeling complexes, ySWI/SNF (yeast
SWI/SNF complex) and RSC, that regulate different,
largely non-overlapping sets of genes (6). Based on com-
parative expression analyses of yeast snf2 and swi1
mutants, it can be estimated that ySWI/SNF regulates
roughly 6% of all S. cerevisiae genes (8). In contrast to
RSC, ySWI/SNF is not essential for the viability of yeast
cells (9). These all demonstrates that despite their common
chromatin remodeling functions, these complexes are
highly speciﬁc for different promoters. In human cells,
which contain multiple SWI/SNF-like complexes, the dis-
tribution of regulatory functions between these complexes
is even more elaborate (10).
A central question is, how the speciﬁcity of different
SWI/SNF complexes for certain sets of promoters is
achieved. In vitro analyses revealed that interaction of
ySWI/SNF with the activation domain of Gcn4p, a tran-
scriptional activator of amino acid biosynthetic genes, is
necessary for recruitment of ySWI/SNF to Gcn4p-
regulated promoters (11,12). Similarly, ySWI/SNF was
shown to interact with the acidic activation domains of
Swi5p known to recruit ySWI/SNF to the yeast HO
promoter, or of Hap4p that regulates respiratory func-
tions (12). Interaction of ySWI/SNF was even observed
with the acidic activation domain of VP16, a transcrip-
tional regulator of Herpes simplex virus (12,13), or with
Gal4p-AH, a fusion of the Gal4p DNA-binding domain
and a synthetic acidic helix (AH) (13). This led to the
model that activation domain-mediated targeting of
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responsible for transcriptional activation.
In screens for ySWI/SNF components directly involved
in this physical interaction with activation domains, the
subunits Swi1p, Snf2p and Snf5p from S. cerevisiae could
be characterized as interactors (14,15). Further analyses
with in vitro-translated fragments of these three subunits
identiﬁed two speciﬁc contact sites, one in the N-terminal
domain of Snf5p and one in the second quarter of Swi1p
(16,17).
No contact-speciﬁc interaction site could be determined
for Snf2p from S. cerevisiae. However, interaction was
demonstrated for one of two Snf2p orthologs from the
SWI/SNF complex from man. These orthologs are
human Brahma [hBrm (18)] and Brahma/SWI2-related
gene 1 [BRG1 (19)]. BRG1 was shown to interact via its
N-terminal helicase/SANT-associated (HAS) domain with
the nuclear glucocorticoid receptor (20). This receptor
targets the mammalian SWI/SNF complex to promoters
containing glucocorticoid response elements (21).
SWI/SNF complexes can also repress transcrip-
tion (5,10). The mammalian NuRD (nucleosome
remodeling and histone deacetylation) complex was the
ﬁrst SWI/SNF-related complex shown to contain a
histone deacetylase activity that is thought to be respon-
sible for repression (22). In S. cerevisiae, ySWI/SNF is
involved in the repression of the SER3 gene that encodes
a phosphoglycerate dehydrogenase catalyzing a step in
serine biosynthesis (23). However, SER3 repression
depends on the enhanced expression of the non-coding
SRG1 gene (SER3 regulatory gene 1) 50 from SER3 (24).
ySWI/SNF is necessary for the induction of SRG1 expres-
sion and, thus, only indirectly for the repression of SER3
(25).
We previously characterized the product of the
S. cerevisiae VHT1 gene, Vitamin H Transporter 1,
which encodes an H
+/biotin symporter of the yeast
plasma membrane (26). VHT1 is expressed only at low
biotin concentrations. We demonstrated that the expres-
sion levels of VHT1 and BIO5 (Biotin biosynthesis 5), the
gene of a plasma membrane transporter for the biotin
biosynthetic precursor 7-keto-8-aminopelargonic acid
(27), are regulated by Vhr1p [VHT1 regulator 1 (28)]
that binds to a vitamin H-responsive element (VHRE) in
the VHT1 and BIO5 50-untranslated regions (28,29).
Here, we show that ySWI/SNF is essential for the in-
duction of VHT1 and BIO5 expression, and that Snf2p is
a central player in this regulation. An snf2 mutant was
identiﬁed in a complementation screen for S. cerevisiae
mutants that had lost the capacity to express the gene of
the green ﬂuorescent protein (GFP) from the VHT1
promoter. Unexpectedly, this snf2 mutation turned out
to speciﬁcally affect only the induction of VHT1 and
BIO5, but not the induction of SUC2, INO1 and GAL1
or the repression of SER3. Sequencing of the snf2 mutant
allele identiﬁed a point mutation near the N-terminus of
Snf2p that converts a conserved arginine at position 15
into a cysteine (R15C). Our data reveal a novel mechanism
for target gene-speciﬁc ySWI/SNF recruitment in yeast via
the N-terminus of Snf2p.
MATERIALS AND METHODS
Yeast strains and plasmids
Yeast strains used in this study are listed in Table 1.
Strains FY3 and YBC3010 were gifts from Bradley
Cairns (Salt Lake City, University of Utah, UT, USA).
For deletion of VHR1 in YBC3010, the Klyveromyces
lactis URA3 disruption cassette of pUG72 (30) was
ampliﬁed by PCR with the primers YIL056W-ko-50 and
YIL056W-ko-30. Disruption of VHR1 was conﬁrmed by
PCR with appropriate primers. The resulting strain was
called MWY8003.
The mutant strain AMYmut153 (snf2-R15C) was com-
plemented with two plasmids from a YEp24 (2-m
plasmid)-based yeast genomic library (31) that contained
SNF2 as the only full-length open reading frame (ORF),
including 3475bp and 191bp, or 3466bp and 205bp of
upstream and downstream sequence, respectively. The
SNF2 gene, together with 2881bp of upstream and
191bp of downstream sequence, was isolated by restric-
tion digest of one of the complementing plasmids with
XmaI and was cloned into the XmaI-linearized single
copy vector YCplac33 (32) yielding plasmid pMW814.
The mutation of the snf2-R15C allele was introduced into
pMW814 by site-directed mutagenesis with the primer
ScSNF2+26f-mut153+T (Table 2) using the QuikChange
Multi Kit (Stratagene, La Jolla, CA, USA). This primer
also introduced a second, silent mutation into the SNF2
ORF that destroyed a HincII to allow identiﬁcation of
mutated plasmids by restriction digest analysis. Sequence
analysis of the resulting ORF conﬁrmed that the encoded
Snf2 protein differed only in the desired Arg to Cys
exchange from the WT protein encoded by the original
plasmid. The resulting plasmid was called pMW817.
A partial genomic sequence for an Snf2p-myc tag was
ampliﬁed with the primers S3-SNF2 and S2-SNF2 from
plasmid pYM6 (33) and inserted via homologous recom-
bination into the SNF2 locus of MWY760gc yielding
strain MWY760gc-SNF2-myc. The 30-end of this
modiﬁed SNF2 sequence was ampliﬁed by PCR
(ScSNF2c+5047f and TRP primer), cloned into pJet1.2,
sequenced and ligated via the BglII and XhoI restriction
sites of this fragment into the BamHI/XhoI-cut yeast
single copy vectors pMW814 or pMW817 that contain
WT SNF2 or mutated snf2-R15C genomic sequences,
Table 1. Yeast strains used in this study
Strain Genotype Reference/Source
JS91.15-23 MAT, his3-D1, leu2-3, trp1-289,
ura3-52, can1
(51)
JSYvht1 Isogenic to JS91.15-23; vht1::HIS3 (26)
MWY760gc Isogenic to JS91.15-23; vht1p::ADH1p (28)
AMYmut153 EMS mutant of MWY760gc; snf2-153 This study
BY4741 MATa, his3-D1, leu2-D0,
met15-D0, ura3-D0
EUROSCARF
Y01586 Isogenic to BY4741; snf2::kanMX4 EUROSCARF
Y01250 Isogenic to BY4741; swi3::kanMX4 EUROSCARF
FY3 MATa, ura3-52 (52)
YBC3010 Isogenic to FY3;
SNF2-13myc::kanMX
Bradley Cairns
MWY8003 Isogenic to YBC3010; vhr1::klURA3 This study
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BglII/XhoI insertions encoded Snf2p-myc or snf2p-
R15C-myc proteins.
Media, EMS mutagenesis, growth tests and induction tests
Ethyl methanesulfonate (EMS) mutagenesis and the com-
plementation screening procedure were carried out as
described (28). The stability of the identiﬁed mutants (=
no revertants) and the absence of mutations in the GFP
sequence were tested as published (28).
Rich medium and synthetic media with deﬁned vitamin
concentrations were prepared as described earlier (28).
For growth tests on petri plates, yeast cells were suspended
to an OD600 of 0.2 in ice cold water, diluted 1:8, 1:64 and
1:512, and 3ml of each dilution were spotted onto the
agar. For the growth tests with deﬁned biotin concentra-
tions, 1% agarose was used instead of agar agar. Media
for induction tests of relevant genes were prepared as
described elsewhere (28,34–36). Where rich medium
could not be used for the induction tests (e.g. maintenance
of plasmids), synthetic medium with 0.67% yeast nitrogen
base and 2% casamino acids (Difco, Augsburg, Germany)
was used. For the induction of GAL1, SUC2 or INO1,
yeasts were grown for one generation time in the respect-
ive medium. Induction of VHT1 was performed as
described (28).
Western blot analyses
Western blots were made after 8% sodium dodecylsulfate
(SDS)–polyacrylamide gel electrophoresis with a monoclo-
nal primary antibody against myc (9E10; Sigma,
Taufkirchen, Germany) and a polyclonal rabbit antibody
against puriﬁed S. cerevisiae alcohol dehydrogenase (gift
from Prof. Christian Koch, University of
Erlangen-Nuremberg, Germany). Secondary horse-radish
peroxidase coupled anti-mouse antibody and anti-rabbit
antibody were from Sigma (Taufkirchen, Germany).
Antibody-binding was visualized with the ECL
Lumilight-Kit from Roche (Mannheim, Germany).
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed
essentially as described (37) after a protocol adapted
from (38) and (39). Antibodies used for ChIP assays
were anti-myc 9E11 (Dianova, Hamburg, Germany) and
aGFP MAB3580 (Chemicon/Millipore, Schwalbach,
Germany). Dynabeads Protein G (Dynal/Invitrogen,
Karlsruhe, Germany) were used as matrix. Primers used
for ampliﬁcation were ScVHT1g-361f and ScVHT1g-144r
for the VHT1 promoter, and ScACT1g+611f and
ScACT1g+813r for normalization to the ACT1 ORF.
Real-time PCR was carried out as described (28).
RNA isolation and real-time reverse transcription PCR
RNA isolation and RT-PCRs were performed as
described earlier (28). Oligonucleotides used for the
ampliﬁcation were ScACT1g-4f and ScACT1g+498r
for ACT1, ScVHT1g+607f and ScVHT1g+808r for
VHT1, ScBIO5g+1040f and ScBIO5g+1244r for BIO5,
YIL056Wg+1411f and YIL056Wg+1617r for VHR1,
ScSUC2g-1f and ScSUC2g+207r for SUC2, ScGAL1c+
1379 and ScGAL1c+1576r for GAL1, ScINO1c+1316f
and ScINO1c+1531r for INO1 and ScSER3c+1084f and
ScSER3c+1286r for SER3.
RESULTS
Identiﬁcation of Snf2p as a factor involved in VHT1
induction at low biotin concentrations
In a previous study, we identiﬁed the S. cerevisiae tran-
scriptional regulator Vhr1p, the prototype of a new family
of transcription factors, and showed that it is essential
for induction of VHT1 and BIO5 at low biotin concentra-
tions (28). VHT1 and BIO5 encode plasma membrane-
localized transporters for biotin (vitamin H; Vht1p) or
for its biosynthetic precursor 7-keto-8-aminopelargonic
acid (Bio5p). The screen was performed with a strain
(MWY760gc) that expressed VHT1 under the control of
the constitutive ADH1 promoter allowing growth on low
and high biotin. In addition, MWY760gc harbored a
plasmid with a VHT1 promoter (pVHT1)::GFP reporter
cassette that drove expression of GFP only on low biotin
(28). For the identiﬁcation of VHR1, 150000 EMS-
mutagenized cells were analyzed.
To identify additional components of the
biotin-dependent signaling cascade, we performed a new
EMS mutagenesis on MWY760gc cells and screened add-
itional 600000 clones for loss of GFP ﬂuorescence on low
biotin. Fifteen newly obtained mutants were transformed
with an S. cerevisiae genomic library (31) and a minimum
of 200000 transformants of each line was screened for
recovery GFP ﬂuorescence on low biotin. With 10 lines
the complementation was successful, and for 8 lines the
complementing sequences could be determined and
assigned to complementation groups. The largest comple-
mentation group with 6 lines contained fragments carrying
the VHR1 gene (data not shown) conﬁrming our previous
results (28). One line was complemented by the ECM1
gene (40) encoding a poorly characterized protein
involved in cell wall biosynthesis (data not shown). This
gene was not further analyzed. The last line, AMYmut153,
was complemented by two different library inserts, each
containing SNF2 as the only full-length gene (Figure 1A).
To independently prove or disprove the identity of SNF2
as the complementing gene, the SNF2 coding sequence
plus 2881bp upstream and 191bp downstream sequences
was cloned into the single copy vector YCplac33 (32). The
resulting plasmid, pMW814, was used to transform
AMYmut153. GFP ﬂuorescence was recovered only in
the pMW814-transformed strain but not in the vector
control (Figure 1A), which conﬁrmed the importance of
Snf2p for VHT1 expression. We also analyzed expression
of VHT1 in the snf2 deletion mutant Y01586
(EUROSCARF, Frankfurt/Main, Germany) by quantita-
tive RT-PCR (qRT-PCR; Figure 1B). In agreement with
the previous data, the snf2 strain failed to induce VHT1
under low biotin conditions. We ﬁnally tested if a mutation
in another subunit of the ySWI/SNF complex will also
abolish VHT1 induction. We, therefore, analyzed VHT1
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on low and high extracellular biotin by qRT-PCR
(Figure 1B). In fact, also the swi3 mutant was unable
to induce VHT1 under low biotin conditions, underlining
the essential role of the ySWI/SNF complex for induction
of VHT1.
A single amino acid exchange in the N-terminus of Snf2p
is responsible for the lack of VHT1 induction
When we sequenced the snf2 mutant allele of the EMS-
mutant strain, AMYmut153 from  830bp upstream
from the start-ATG to 52bp downstream of the stop-
codon, we found a single point mutation in the codon for
the arginine residue at position 15 in Snf2p. This mutation
changed CGC into TGC, which replaced the arginine
at position 15 by a cysteine yielding snf2p-R15C. A com-
parison of the Snf2p sequences from different fungi
demonstrated that this amino acid is highly conserved
in Snf2 proteins from other species of the order
Saccharomycetales (Figure 2A). Occasionally, this
arginine can be replaced by a lysine residue (see the
sequence of the Candida dubliniensis Snf2 protein in
Figure 2A).
Sequence alignments revealed that this arginine is
embedded in a conserved domain of about 50 amino
acids at the very N-terminus of these Snf2 proteins
(Figure 2A). This conserved N-terminal domain is found
exclusively in yeast Snf2 proteins, and is followed by a 100–
250 amino acid region of low sequence similarity. To ﬁnd
possibly conserved structural motifs within this region, we
performed in silico analyses on the ﬁrst 100 amino acid
of S. cerevisiae Snf2p and of 9 other Snf2 proteins with
the Protein Homology/analogY Recognition Engine
[PHYRE; http://www.sbg.bio.ic.ac.uk/phyre/ (41); output
ﬁles are presented in Supplementary Figure S1]. In fact, all
analyses revealed an identical structure for each of these
sequences (Figure 2B). An a-helix of about 17 amino acids
(a1) is predicted to start 6–10 amino acids downstream
from the start methionine, and a short stretch of 6–7
disordered residues separates this ﬁrst helix from a
second, slightly longer a-helix (a2) of 18–25 amino acids.
This a2-helix is followed by a longer disordered region
(Figure 2B and Supplementary Figure S1).
The helices and the disordered sequences are predicted
with maximal probability. In all predictions, the arginine
residue modiﬁed in our EMS mutant and the conserved
arginine or lysine residues in the other Snf2 proteins
are located in the ﬁrst half of the a1-helix. Based on the
functional characterization of the snf2p-R15C protein
(see below), we refer to this conserved structural
motif in Snf2p as EVA (expression of VHT1 activating)
domain.
To exclude the possibility that the observed snf2-R15C
mutation results in a reduced amount of snf2p-R15C
protein, e.g. as a result of reduced stability of the
mutant protein, we compared the amounts of Snf2p and
snf2p-R15C proteins in yeast cells. To this end, we
generated single copy plasmids encoding modiﬁed Snf2p
and snf2p-R15C proteins with C-terminal myc tags
(Snf2p-myc and snf2p-R15C-myc) and expressed these
constructs in the snf2 mutant strain Y01586. The
amounts of Snf2p-myc and snf2p-R15C-myc were
compared on western blots treated with anti-myc anti-
serum (anti-myc-AB). Figure 2C shows that the amount
of snf2p-R15C-myc proteins is not decreased compared
with the Snf2p-myc control.
Figure 1. Identiﬁcation of the ySWI/SNF complex as an essential
component of VHT1 induction. (A) SNF2 complements the
non-ﬂuorescence phenotype of the EMS mutant AMYmut153. Images
show the GFP ﬂuorescence resulting from a pVHT1::GFP construct in
the WT (MWY760gc) or in the AMYmut153 mutant. Strains were
complemented with one of the SNF2-containing multicopy (mc)
plasmids identiﬁed in the complementation screen or with a single copy
(sc) plasmid (pMW814) harboring SNF2. Vector controls (A) carried the
plasmid YEp24. Numbers show insert lengths relative to the SNF2 start
ATG. Plates were photographed in white light and under GFP excitation
light. (B) Real-time RT-PCR analysis of VHT1 mRNA levels in the WT
and in mutants lacking subunits of the ySWI/SNF complex (snf2 or
swi3). RT-PCRs were performed with total RNA from yeasts grown
on SD medium containing the indicated biotin concentrations. Results
were standardized to ACT1 mRNA levels (n=3; ±SE).
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inducing conditions
To test, if the observed Snf2p mutation reduces the expres-
sion of VHT1 indirectly by affecting the expression of
VHR1, the gene for the transcriptional regulator of
VHT1, we compared VHR1 mRNA levels in the snf2
strain Y01586 and in the corresponding wild type (WT)
strain BY4741 (EUROSCARF) on low biotin. qRT-PCR
reactions revealed no differences in the expression of
VHR1 (Figure 3) suggesting that the snf2-R15C mutation
affects VHT1 expression directly, and that WT ySWI/SNF
may bind directly to pVHT1.
We tested this hypothesis in ChIP analyses with strain
YBC3010 that contains a myc-tagged version of Snf2p
(Snf2p-myc). We assayed binding of Snf2p-myc to the
vitamin H-responsive element (VHRE) relative to its
binding to the ACT1 ORF. We could conﬁrm that
Snf2p-myc is present at the VHRE at low, VHT1-
inducing biotin concentrations (Figure 4). The signal
obtained at non-inducing, high biotin concentrations
was signiﬁcantly lower and comparable with the signals
obtained in two negative controls (Snf2p with no myc-tag
or Snf2p-myc with a control antiserum against GFP,
aGFP; Figure 4A). We also assayed binding of
Snf2p-myc in a vhr1 deletion strain. In this strain,
Snf2p-myc was not recruited to the VHRE, even when
the cells were grown on low biotin. In summary, these
data demonstrate (i) that Snf2p occupies the pVHT1, (ii)
that this recruitment occurs at or near the VHRE element,
(iii) that the presence of Vhr1p is essential to recruit Snf2p
to the VHRE and (iv) that Vhr1p targets Snf2p to the
VHT1 promoter only at low biotin concentrations, i.e.
under conditions, when VHT1 expression is induced.
snf2p-R15C cannot occupy pVHT1
The ﬁnding that Snf2p occupies the pVHT1 (Figure 4A)
suggested that this recruitment of Snf2p might be specif-
ically affected by the mutation in the snf2p-R15C protein.
To test this hypothesis, we performed additional ChIP
analyses with three yeast strains expressing SNF2,
SNF2-myc or snf2-R15C-myc in the background of the
snf2 mutant strain Y01586 at low, VHT1-inducing
biotin concentrations. Figure 4B demonstrates that as
shown in Figure 4A Snf2p-myc occupies the pVHT1.
Most importantly, however, Figure 4B also demonstrates
that snf2p-R15C is not recruited to the VHRE. Together
with the data shown in Figure 4A, this result shows that
snf2p-R15C fails to induce VHT1 expression, because its
Figure 2. Alignment of N-terminal Snf2 protein sequences and comparative expression analyses. (A) The ﬁrst 70 amino acids of S. cerevisiae Snf2p
and the corresponding residues of Snf2 proteins from other members of the order Saccharomycetales. Amino acids identical in all proteins are
highlighted. The arginine at position 15 in Snf2p is highlighted in black, predicted a-helices are underlined. (B) Model of the predicted secondary
structure for Snf2p EVA domains. The position of the conserved arginine/lysine is indicated. (C) Western blot analysis of the relative amount of
Snf2p-myc and snf2p-R15C-myc in extracts of cells expressing the corresponding genes. An extract of cells expressing SNF2 without a C-terminal
fusion is shown to demonstrate the speciﬁcity of the anti-myc antiserum (anti-myc). Each lane was loaded with 5mg of protein extract. Signals
obtained from the same blot with an anti-Adh-antiserum (anti-Adh) are shown as loading controls.
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of Snf2p to the VHRE element in pVHT1.
ySWI/SNF mutants cannot grow on low biotin
concentrations due to the lack of VHT1 expression
Based on the data presented so far (Figures 1B, 3 and 4),
we expected that snf2 mutants should be severely affected
in their capacity to grow on low biotin. We, therefore,
compared the growth of the snf2 mutant, of the corres-
ponding SNF2 WT and of a vht1 deletion mutant
[JSYvht1 (26)] on SD media with decreasing biotin con-
centrations. As expected, the vht1 mutant did grow only
on high biotin (2mg biotin l
 1; Figure 5). Also the snf2
cells failed to grow on medium with low biotin (0.02mg
biotin l
 1; Figure 5). The growth difference between vht1
and snf2 cells on medium biotin concentrations (200mg
biotin l
 1) results from a weak basal activity of pVHT1 in
snf2 cells and the complete absence of Vht1p activity in
vht1 cells.
At high and medium biotin concentrations, the snf2
cells grow slower than the WT (Figure 5), a well-known
behavior of ySWI/SNF mutants on glucose media (42).
Transformation of the snf2 mutant with the pVHT1oe
plasmid that expresses VHT1 under the control of the
constitutive ADH1 promoter (26) complemented only
the growth defect on low biotin, but not the slower
growth of the snf2 mutant at higher biotin concentra-
tions (Figure 5). The same results were obtained in experi-
ments performed with the swi3 deletion mutant Y01250
(not shown). In summary, these results conﬁrmed that
mutations in ySWI/SNF subunits result in a lack of
biotin-dependent VHT1 induction (Figure 1B) and conse-
quently in a reduced capacity to grow on low biotin
(Figure 5).
The snf2-R15C mutant has an unusual phenotype
Compared with WT cells, snf2 mutants exhibit slow
growth on glucose [Figure 5 and (42,43)], fail to grow
on galactose and rafﬁnose (42,43), and are auxotrophs
for inositol (44). This was re-conﬁrmed in comparative
growth analyses on media with galactose (YPGal) or raf-
ﬁnose (YPRaf) as sole carbon source, on medium w/o
inositol (SD w/o inositol), or on glucose-containing
yeast peptone dextrose (YPD) medium (Figure 6).
Surprisingly, however, the snf2-R15C mutant did not
Figure 4. ChIP analyses with Snf2p-myc and snf2p-R15C-myc. (A) ChIPs of Snf2p-myc were performed in a VHR1 WT (YBC3010), a vhr1 mutant
(MWY8003) and in a VHR1 control strain (FY3) expressing untagged SNF2. ChIP was also performed in the SNF2-myc, VHR1 strain (YBC3010)
with a control antibody (aGFP). Yeast cells were grown on SD medium containing the indicated biotin concentrations. Binding of Snf2p-myc to the
VHT1 promoter was assayed relative to its binding at the ACT1 ORF. Input control and immunoprecipitated DNA (IP) were ampliﬁed with primers
spanning a region containing the VHT1 promoter vitamin H-responsive element (VHRE). Snf2p occupancy was calculated as ratio of the VHT1
signal in the IP-to-input samples and normalized for the corresponding ratio calculated for ACT1. The mean value for Snf2p-myc under inducing
conditions was set to 100% (n=3; ±SE). (B) ChIPs of Snf2p (control), Snf2p-myc and snf2p-R15C-myc were performed in the snf2 mutant strain
Y01586 expressing SNF2 (control), SNF2-myc or snf2-R15C-myc from a single copy plasmid under the control of the SNF2 promoter. Binding of
Snf2p-myc and snf2p-R15C-myc to the VHT1 promoter was assayed as described in (A). The mean signal obtained with the control strain expressing
untagged SNF2 was set to 1 (n=3; ±SE).
Figure 3. qRT-PCR of VHR1 mRNA levels. VHR1 mRNA levels were
determined in the snf2 deletion mutant and in the corresponding WT
on low biotin medium. Results were standardized to ACT1 mRNA
(n=3; ± SE).
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all media (Figure 6). Moreover, this growth could not be
further improved by expressing WT SNF2 from one of the
multicopy plasmids (snf2-R15C + SNF2mc) identiﬁed in
the complementation screening (Figure 1A) or from the
single copy plasmid (snf2-R15C+SNF2sc) used to express
SNF2 in the AMYmut153 strain (Figure 1A). This
demonstrated that the snf2-R15C mutation does not
exhibit any of the previously published growth phenotypes
of a snf2 deletion mutant. It rather suggested that the
snf2-R15C mutation is hypomorphic allele that speciﬁcally
affects the regulation by Vhr1p and the targeting of ySWI/
SNF to the VHRE.
snf2p-R15C fails to induce VHT1 and BIO5, but mediates
WT-like expression of the ySWI/SNF-dependent genes
SUC2, GAL1, INO1 and SER3
The unexpected WT-like growth of the snf2-R15C mutant
on YPGal and YPRaf medium or on SD medium w/o
inositol pointed toward a normal, WT-like expression of
the responsible ySWI/SNF target genes, GAL1, SUC2 and
INO1. We tested the expression of these genes by RT-PCR
in the SNF2 WT, the snf2 strain and the snf2-R15C
mutant that were grown on media inducing the expression
of SUC2 (YPRaf), GAL1 (YPGal) or INO1 (SD medium
w/o inositol). Moreover, we analyzed the expression of
SER3, a gene of the serine biosynthetic pathway known
to be de-repressed in snf2 mutants on rich medium (25).
As expected, the mRNA levels of all genes were compar-
able in the SNF2 WT strain and in the snf2-R15C mutant
(Figure 7), whereas the snf2 deletion mutant failed to
induce expression of GAL1, SUC2 and INO1, and did
not repress SER3.
We could not include analyses of VHT1 expression in
Figure 7, as the snf2-R15C mutant used in these analyses
(AMYmut153; see Figure 1) expressed VHT1 from the
constitutive ADH1 promoter. For a direct comparison
of the snf2-R15C-dependent induction of VHT1 with the
induction/repression of other ySWI/SNF target genes in
WT and snf2 cells, we introduced the snf2-R15C
mutation into the single copy plasmid pMW814 used in
Figure 1 by site-directed mutagenesis. We next trans-
formed the snf2 strain Y01586 either with this plasmid
to obtain the snf2-R15C genotype, with the SNF2 WT
plasmid to regain the WT gene, or with the empty
vector to maintain the snf2 genotype. To study the ex-
pression of VHT1, GAL1 and SER3 by quantitative
real-time RT-PCR, these three strains were grown either
on SD medium with low biotin (0.2mgl
 1; Figure 8A), on
galactose medium (Figure 8C), or on CAA medium
(Figure 8D). Moreover, we included analyses of BIO5 ex-
pression, another gene induced by the Vhr1p transcription
factor on low biotin [Figure 8B and ref. (28)].
As expected, expression of VHT1 was very high in the
SNF2-complemented snf2 mutant, but negligible in the
vector control and in the snf2-R15C complemented
strain (Figure 8A), which conﬁrmed our previous experi-
ments (Figures 1, 4 and 5). A very similar result was
obtained for BIO5 (Figure 8B), which demonstrated
that the snf2-R15C mutation affects the expression of
other Vhr1p-regulated genes in the same way as VHT1.
In contrast, and in agreement with the data shown
in Figures 6 and 7, snf2-R15C and snf2 differed in
Figure 6. Growth test to assay phenotypes of ySWI/SNF mutants. Yeast strains were grown on the indicated media to assay the following pheno-
types: slow growth (YPD), inability to use the sugars galactose or rafﬁnose as carbon sources (YPGal and YPRaf), and inositol auxotrophy (SD w/o
inositol). The SNF2 WT (top) and the snf2 mutant (bottom) were used as controls to assay the growth behavior of the snf2-R15C mutant. In
addition, the effects of SNF2 expression from one of the complementing multicopy plasmids (snf2-R15C + SNF2mc; Figure 1A) or from an SNF2-
containing single copy plasmid (snf2-R15C+SNF2sc) were analyzed. To allow growth on the same medium, control strains were transformed with the
empty plasmid YEp24. Cells were spotted on plates after serial 1:8 dilutions.
Figure 5. Growth test on SD medium with varying biotin concentrations. The snf2 mutant was transformed with plasmid pVHT1oe, expressing
VHT1 from the constitutive ADH1 promoter (snf2+VHT1oe). To allow growth on the same medium, the deletion mutants vht1 and snf2 and
the WT were transformed with the empty vector NEV-E. Cells were spotted on SD medium containing the indicted biotin concentrations after serial
1:8 dilutions, grown for 3 days and photographed.
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(Figure 8C), and in their capacity to repress SER3
(Figure 8D). The expression of both genes was identical
in snf2-R15C complemented and SNF2 complemented
cells. Again this conﬁrmed that the snf2p-R15C allele
encodes a protein capable to regulate well-known ySWI/
SNF target genes, such as GAL1 or SER3. In contrast, its
capacity to induce Vhr1p-regulated genes, such as VHT1
and BIO5, is completely lost.
DISCUSSION
The nucleosome remodeling ATPase Snf2p represents the
central catalytic subunit of the ySWI/SNF complex that
regulates a large number of S. cerevisiae genes (6,7,45). In
a complementation screen for transcriptional regulators of
VHT1, the gene of the biotin/H
+symporter, we identiﬁed
a novel snf2 mutant allele (Figure 1A). We veriﬁed the
importance of Snf2p and the ySWI/SNF complex for
VHT1 induction in additional analyses of snf2 and
swi3 mutants (Figure 1B) and characterized VHT1 and
BIO5 as previously unidentiﬁed target genes of ySWI/
SNF. They were not identiﬁed in former large-scale
searches for ySWI/SNF target genes (5), as VHT1 and
BIO5 stay repressed under the high biotin conditions
applied in these experiments.
The R15C mutation in the newly identiﬁed snf2p mutant
allele is located in the ﬁrst of two a-helices in the structur-
ally conserved EVA domain found in the Snf2p proteins
of all Saccharomycetes (Figure 2A and Supplementary
Figure S1). Occasionally, e.g. in Snf2p of Debaryomyces
hansenii (accession number XP_461680) or Candida
dubliniensis (accession number CAX43468), this conserved
arginine can be replaced by a lysine residue. Both, this
conserved basic residue and the EVA domain, are absent
from other chromatin remodeling ATPases of S. cerevisiae
Figure 8. qRT-PCR analysis of mRNA levels of VHT1, BIO5 and
GAL1 under inducing conditions and of SER3 under repressing condi-
tions. The snf2 deletion mutant was transformed with the single copy
plasmids harboring the SNF2 gene, with the snf2-R15C mutant allele, or
with the YEp24 vector (maintaining the snf2 genotype). After growth
in CAA liquid medium, cultures were split and incubated in the fol-
lowing media: (A) and (B) in low biotin medium, (C) in CAA medium
supplemented with 2% galactose, (D) CAA medium with 2% glucose.
Results were standardized to ACT1 mRNA levels; expression levels in
SNF2 complemented cells were set to 100% (n=3;±SE).
Figure 7. Comparative qRT-PCR analysis of the expression of typical
ySWI/SNF target genes. RT-PCR analysis of mRNA levels of SUC2,
GAL1 and INO1 under inducing conditions, and of SER3 under re-
pressing conditions. The snf2-R15C mutant strain, the snf2 deletion
mutant and the WT strain were ﬁrst grown in YPD medium, cultures
were split and incubated in the indicated media.
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Ino80p and Swr1p proteins, and also the closely related
Sth1p protein of the RSC complex (46). This points
toward a conserved function of Snf2p N-termini.
Binding of Snf2p to the VHT1 promoter depends on the
presence of Vhr1p
ChIP analyses conﬁrmed the presence of Snf2p at the
VHT1 promoter in a 200-bp region (Figure 4) containing
the VHRE essential for biotin-dependent VHT1 induction
(28,29). This binding of Snf2p was detected only under
inducing conditions, i.e. at low biotin. The binding of
Snf2p also depended strictly on the presence of Vhr1p,
the transcriptional regulator. No binding was detected in
a vhr1 deletion mutant (Figure 4) that is unable to
induce VHT1 (28). This demonstrated that Vhr1p is essen-
tial for Snf2p recruitment to the VHT1 promoter. It is,
however, not yet possible to distinguish whether there is a
direct or indirect interaction between Vhr1p and the
N-terminus of Snf2p.
The snf2-R15C mutant represents a hypomorphic allele
Surprisingly, the snf2-R15C mutant did not show the slow
growth phenotype on glucose, the growth defects on
galactose or rafﬁnose (42), and the inositol auxotrophy
(44) characteristic for snf2 strains (Figure 6).
Moreover, expression of genes (GAL1, INO1 and SUC2)
that are miss-regulated in the snf2 mutants and respon-
sible for these growth phenotypes was not affected in the
snf2-R15C mutant (Figure 7). Similarly, expression of
SER3, a gene repressed in SNF2 WT strains but not in
the snf2 mutant (23) was not affected in the snf2-R15C
mutant. In contrast, both the snf2-R15C mutation and the
snf2 deletion resulted in a loss of VHT1 and BIO5 in-
duction (Figure 8). This characterized snf2-R15C as a
hypomorphic allele that affects Snf2p function only for
Vhr1p-regulated target promoters.
Induction of Vhr1p target genes by Snf2p reveals a novel
mechanism of ySWI/SNF recruitment
In summary, the protein encoded by the snf2-R15C allele
acts like WT Snf2p on most ySWI/SNF target promoters,
but it is unable to induce VHT1, BIO5 and putatively
also other Vhr1p-regulated genes. Thus, the R15C
mutation and the conserved EVA domain (Figure 2 and
Supplementary Figure S1) seem to be crucial for VHT1
and BIO5 induction, but are dispensable for the regulation
of most other ySWI/SNF target genes. This suggests that
the transcriptional regulator Vhr1p recruits the ySWI/
SNF complex to the VHT1 promoter via its N-terminal
EVA domain.
This is in line with a report that suggested multiple
functional domains for Snf2p, especially in its
N-terminus (47). In fact, the N-terminal region preceding
the Snf2p ATPase domain is accessible for protein/protein
interactions, as a 50-amino acid stretch (also named
domain 1=residues 239–289) was shown to interact
with Snf11p, another ySWI/SNF subunit (48).
Moreover, the crystal structure of the bacterial Snf2p
homolog RapA, the only available crystal structure of a
full-length Snf2 protein, demonstrates that the N-terminus
of Snf2p is freely accessible and probably points away
from the DNA helix (49).
In summary, the characterization of the mutant allele
snf2-R15C reveals a novel mechanism of ySWI/SNF re-
cruitment to its target promoters. Interactions between
other subunits of the ySWI/SNF complex and transcrip-
tional regulators have been described. The Gal4p tran-
scription factor, for example, recruits ySWI/SNF to the
GAL1 promoter by interactions with the subunits Swi1p
and Snf5p (17), and Gcn4p recruits ySWI/SNF via the
subunits Snf5p, Swi3p and Snf6p (50). Interestingly,
Snf2p was shown to be important for the repression of
SER3 whereas neither Swi1p nor Swi3p is required for
this repression (23). For Snf2p a direct contact to or at
least a close proximity with transcriptional activators has
also been suggested (15); however, a speciﬁc interaction
site has so far not been identiﬁed and a target gene-speciﬁc
role of the ySWI/SNF ATPase unit has never been
demonstrated. Obviously, the N-terminal site of Snf2p
shown to be important for the induction of VHT1 or
BIO5 is not involved in the Snf2p-dependent repression
of SER3 (Figure 8).
Table 2. Oligonucleotides used in this study
Oligonucleotide Sequence
ScACT1g-4f AACAATGGATTCTGAGGTTGCTGC
ScACT1g+498r TCTCTTGGATTGAGCTTCATCACC
ScACT1g+611f CCCTGTTCTTTTGACTGAAGC
ScACT1g+813r AACCAGCGTAAATTGGAACG
ScBIO5g+1040f AAACGGCAGTCGTTGAGTCT
ScBIO5g+1244r TTTCCCAAGGAACCCTCTTT
ScGAL1c+1379 CATATGGTTCCCGTTTGACC
ScGAL1c+1576r ATAGACAGCTGCCCAATGCT
ScINO1c+1316f CTTTACTGGCTACGCCCTTG
ScINO1c+1531r CTAAGGCGGTTCTTTGCTTG
ScSER3c+1084f GAAGTGGCTACCGCATTGTC
ScSER3c+1286r TCGGAAAATTGCTTTTCGAT
ScSNF2+26f-mut153+T GCAACGAAGAGGTCAATTG
CTGCTATTTAAGATGG
ScSNF2c+5047f ACTTCAAGCGTGGCTGAATC
ScSUC2g-1f GATGCTTTTGCAAGCTTTCCTT
ScSUC2g+207r ACCCCATACGGTGTCATTTG
ScVHT1g+607f GGCTGGACTTGGTTCACATT
ScVHT1g+808r CTGAAGTCACGGAACCCAAT
ScVHT1g-361f TGATTGCCTCCATTGCTACA
ScVHT1g-144r GCCTTGCATCTCATATTTCG
S2-SNF2 GTCTACGTATAAACGAATAAGT
ACTTATATTGCTTTAGGAAG
GTAATCGATGAATTCGAGCTCG
S3-SNF2 TCTTTCACAGATGAAGCGGAC
TCGAGCATGACAGAAGCGAG
TGTACGTACGCTGCAGGTCGAC
TRP primer GCTATTCATCCAGCAGGCCTC
YIL056Wg+1411f CCCACGGTGTCTGAAGTTTT
YIL056Wg+1617r GGGCACTGGTATTTTTGCAT
YIL056W-ko-50 TTCTACCTATTCTTCTTCGTTGC
TTATATCCTATACACATCAG
CTGAAGCTTCGTACGC
YIL056W-ko-30 AATGTGTATTAGGCAGTTATGTA
TGTAGACAATTTTGTTTGC
ATAGGCCACTAGTGGATCTG
4096 Nucleic Acids Research, 2011,Vol.39, No. 10To our knowledge, a hypomorphic allele affecting only
a subset of ySWI/SNF target genes has never been
reported. The identiﬁcation and characterization of the
snf2-R15C allele provides new insights into the mechan-
isms allowing gene-speciﬁc action of a machinery that is
involved in the global regulation of gene expression.
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